microRNA-223 Deficiency Exacerbates Acute Inflammatory Response to Monosodium Urate Crystals by Targeting NLRP3

Qi-Bin Yang1,2, Ling-Qin Li1, Quan-Bo Zhang2,3

  • 1Department of Rheumatology and Immunology, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, Sichuan Province, People's Republic of China.

Abstract

Insights

MicroRNA-223 plays a crucial role in regulating gout inflammation. Lower levels of microRNA-223 are found in gout patients, and its deficiency worsens inflammatory responses, suggesting therapeutic potential.

Area of Science:

  • Molecular Biology
  • Immunology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of inflammatory responses.
  • Gout is a type of inflammatory arthritis characterized by the deposition of monosodium urate (MSU) crystals.
  • The specific role of miR-223 in gout pathogenesis remains to be fully elucidated.

Purpose of the Study:

  • To investigate the role of microRNA (miR)-223 in the mechanism of gout.
  • To determine the expression levels of miR-223 in gout patients and in response to MSU crystal challenge.
  • To evaluate the impact of miR-223 deficiency on gouty inflammation in mouse models.

Main Methods:

  • Utilized wild-type (WT) and miR-223 knock-out (KO) mice to model gout.
  • Assessed inflammatory cytokine levels in various lavage fluids.
  • Examined miR-223 expression and pro-inflammatory gene activity in mouse bone marrow-derived macrophages (BMDMs) and human peripheral blood mononuclear cells (PBMCs) in vitro following MSU stimulation.

Main Results:

  • MiR-223 expression was transiently upregulated in WT BMDMs post-MSU challenge but absent in KO mice.
  • miR-223 deficiency exacerbated MSU-induced swelling, inflammatory cell infiltration, and cytokine release (IL-1β, IL-6, MCP-1) in vivo.
  • In vitro, miR-223 deficiency promoted inflammation by targeting NLRP3, and miR-223 levels were downregulated in gout patients and MSU-treated healthy controls.

Conclusions:

  • MiR-223 is downregulated in gout patients.
  • miR-223 deficiency exacerbates gouty inflammation through various mechanisms.
  • Upregulation of miR-223 presents a potential therapeutic strategy for gouty inflammation.